Science ❯ Research ❯ Clinical Trials
Next-Generation Drugs Drug Resistance Personalized Medicine Triple-Negative Breast Cancer Pancreatic Cancer Research Ovarian Cancer Detection Metabolic Dysfunction
The preclinical study reports restored chemotherapy response in lung squamous cell carcinoma after disabling a tumor-specific NRF2 mutation.